ENDRA Life Sciences
NDRA
9 hedge funds and large institutions have $32.9K invested in ENDRA Life Sciences in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 11 closing their positions.
0.93% more ownership
Funds ownership: 0% → 0.93% (+0.93%)
44% less funds holding
Funds holding: 16 → 9 (-7)
59% less capital invested
Capital invested by funds: $80.6K → $32.9K (-$47.7K)
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$178K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$42.5K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$34.6K |
| 4 |
Two Sigma Investments
New York
|
+$31.4K |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
+$22.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$7.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$5.38K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.87K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.67K |
| 5 |
KAS
Kestra Advisory Services
Austin,
Texas
|
-$2.19K |
NDRA Hedge Fund Activity: Q3 2024 in Review
9 of the 6,979 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q3 2024, worth a combined $32.9K — down 59% from $80.6K a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of NDRA and 4 opened new positions — a net loss of 7 holders — while 0 trimmed existing stakes and 5 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $178K. The largest seller was Geode Capital Management, exiting entirely with an estimated $7.4K sold.
- 9 institutional investors held ENDRA Life Sciences (NDRA) as of Q3 2024, down from 16 in Q2 2024.
- Funds reported $32.9K of ENDRA Life Sciences stock for Q3 2024, down 59% quarter-over-quarter.
- 4 funds opened new ENDRA Life Sciences positions in Q3 2024 and 11 closed out, a net change of -7 holders.
- The largest ENDRA Life Sciences buyer in Q3 2024 was Virtu Financial, an estimated $178K added.
- The largest ENDRA Life Sciences seller in Q3 2024 was Geode Capital Management, an estimated $7.4K sold.
Based on aggregated 13F filings for Q3 2024.